JP4880078B1 - Powder cosmetics - Google Patents
Powder cosmetics Download PDFInfo
- Publication number
- JP4880078B1 JP4880078B1 JP2011115672A JP2011115672A JP4880078B1 JP 4880078 B1 JP4880078 B1 JP 4880078B1 JP 2011115672 A JP2011115672 A JP 2011115672A JP 2011115672 A JP2011115672 A JP 2011115672A JP 4880078 B1 JP4880078 B1 JP 4880078B1
- Authority
- JP
- Japan
- Prior art keywords
- powder
- plate
- weight
- fine particle
- spherical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000843 powder Substances 0.000 title claims abstract description 298
- 239000002537 cosmetic Substances 0.000 title claims abstract description 74
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims abstract description 110
- 239000002131 composite material Substances 0.000 claims abstract description 108
- 239000010419 fine particle Substances 0.000 claims abstract description 108
- 239000002245 particle Substances 0.000 claims abstract description 78
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 58
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims abstract description 58
- 239000011787 zinc oxide Substances 0.000 claims abstract description 57
- 230000000694 effects Effects 0.000 abstract description 23
- 230000006750 UV protection Effects 0.000 abstract description 17
- 229960005196 titanium dioxide Drugs 0.000 description 49
- 235000014692 zinc oxide Nutrition 0.000 description 48
- -1 sericite Substances 0.000 description 38
- 238000011282 treatment Methods 0.000 description 37
- 238000000034 method Methods 0.000 description 30
- 235000014113 dietary fatty acids Nutrition 0.000 description 21
- 239000000194 fatty acid Substances 0.000 description 21
- 229930195729 fatty acid Natural products 0.000 description 21
- 229920001296 polysiloxane Polymers 0.000 description 20
- 238000002156 mixing Methods 0.000 description 17
- 238000000338 in vitro Methods 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 14
- 150000004665 fatty acids Chemical class 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 12
- 239000011248 coating agent Substances 0.000 description 12
- 238000000576 coating method Methods 0.000 description 12
- 239000004205 dimethyl polysiloxane Substances 0.000 description 12
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 12
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 12
- 229940008099 dimethicone Drugs 0.000 description 11
- 238000004381 surface treatment Methods 0.000 description 11
- 239000006096 absorbing agent Substances 0.000 description 10
- 238000010306 acid treatment Methods 0.000 description 10
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 10
- 229940063655 aluminum stearate Drugs 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 239000004359 castor oil Substances 0.000 description 7
- 235000019438 castor oil Nutrition 0.000 description 7
- 238000013329 compounding Methods 0.000 description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- 239000000344 soap Substances 0.000 description 7
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 6
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000010936 titanium Substances 0.000 description 6
- NUHMQHLCUWSBCS-UHFFFAOYSA-N 10-(16-methylheptadecoxy)-10-oxodecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCC(O)=O NUHMQHLCUWSBCS-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 5
- 239000011737 fluorine Substances 0.000 description 5
- 229910052731 fluorine Inorganic materials 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000011812 mixed powder Substances 0.000 description 5
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 5
- 239000004926 polymethyl methacrylate Substances 0.000 description 5
- 229910052582 BN Inorganic materials 0.000 description 4
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- 235000021355 Stearic acid Nutrition 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 230000005661 hydrophobic surface Effects 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 239000010445 mica Substances 0.000 description 4
- 229910052618 mica group Inorganic materials 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000008117 stearic acid Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 229910052719 titanium Inorganic materials 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 229910052628 phlogopite Inorganic materials 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 3
- 235000012239 silicon dioxide Nutrition 0.000 description 3
- 238000006884 silylation reaction Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 150000003751 zinc Chemical class 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 2
- 125000004442 acylamino group Chemical group 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000000378 calcium silicate Substances 0.000 description 2
- 229910052918 calcium silicate Inorganic materials 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000010954 inorganic particle Substances 0.000 description 2
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000002649 leather substitute Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- UGZADUVQMDAIAO-UHFFFAOYSA-L zinc hydroxide Chemical compound [OH-].[OH-].[Zn+2] UGZADUVQMDAIAO-UHFFFAOYSA-L 0.000 description 2
- 229940007718 zinc hydroxide Drugs 0.000 description 2
- 229910021511 zinc hydroxide Inorganic materials 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- AVBJHQDHVYGQLS-AWEZNQCLSA-N (2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-AWEZNQCLSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- NCLNAHJFXIKYBY-UHFFFAOYSA-N 2-hexyldecyl 16-methylheptadecanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C NCLNAHJFXIKYBY-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 241001340526 Chrysoclista linneella Species 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 101000642347 Homo sapiens Splicing factor 45 Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 102100036374 Splicing factor 45 Human genes 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 240000002871 Tectona grandis Species 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- 229910052626 biotite Inorganic materials 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229940105847 calamine Drugs 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- YGANSGVIUGARFR-UHFFFAOYSA-N dipotassium dioxosilane oxo(oxoalumanyloxy)alumane oxygen(2-) Chemical compound [O--].[K+].[K+].O=[Si]=O.O=[Al]O[Al]=O YGANSGVIUGARFR-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 229910052864 hemimorphite Inorganic materials 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- TXGJTWACJNYNOJ-UHFFFAOYSA-N hexane-2,4-diol Chemical compound CCC(O)CC(C)O TXGJTWACJNYNOJ-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 229910052627 muscovite Inorganic materials 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000011146 organic particle Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- ZQTHOIGMSJMBLM-BUJSFMDZSA-N pangamic acid Chemical compound CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O ZQTHOIGMSJMBLM-BUJSFMDZSA-N 0.000 description 1
- 108700024047 pangamic acid Proteins 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920003217 poly(methylsilsesquioxane) Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920003225 polyurethane elastomer Polymers 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 238000007655 standard test method Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229920001909 styrene-acrylic polymer Polymers 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 239000011269 tar Substances 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 150000003608 titanium Chemical class 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
【課題】安全性、使用性及び紫外線防御効果に優れた粉体化粧料を提供する。
【解決手段】 次の成分(A)および(B)(各成分の配合量を表す重量%は、粉体化粧料全体の重量に基づく):
(A)粒子径5〜100nmの微粒子酸化チタンおよび/または粒子径5〜400nmの微粒子酸化亜鉛を粒子径1〜50μmの板状粉体に対し2:8〜7:3の重量比率で被覆した光輝性を有さない板状複合粉体:10〜60重量%、
(B)粒子径5〜100nmの微粒子酸化チタンおよび/または粒子径5〜400nmの微粒子酸化亜鉛を粒子径1〜50μmの球状粉体に対し2:8〜7:3の重量比率で被覆した球状複合粉体:4〜50重量%
を含有する粉体化粧料。
【選択図】なしDisclosed is a powder cosmetic excellent in safety, usability, and UV protection effect.
SOLUTION: The following components (A) and (B) (weight% representing the amount of each component is based on the total weight of the powder cosmetic):
(A) Fine particle titanium oxide having a particle diameter of 5 to 100 nm and / or fine particle zinc oxide having a particle diameter of 5 to 400 nm was coated on a plate-like powder having a particle diameter of 1 to 50 μm in a weight ratio of 2: 8 to 7: 3. Plate-like composite powder having no glitter: 10 to 60% by weight,
(B) A spherical shape in which a fine particle of titanium oxide having a particle size of 5 to 100 nm and / or a fine particle of zinc oxide having a particle size of 5 to 400 nm is coated on a spherical powder having a particle size of 1 to 50 μm in a weight ratio of 2: 8 to 7: 3. Composite powder: 4-50% by weight
Containing powder cosmetics.
[Selection figure] None
Description
本発明は、安全性、使用性及び紫外線防御効果に優れた粉体化粧料に関する。 The present invention relates to a powder cosmetic excellent in safety, usability, and UV protection effect.
パウダーファンデーションや白粉等の粉体化粧料はベースメイク化粧料として肌のしみ・くすみ等のトラブルを隠して自然で美しい仕上がりになることを求められているが、近年は紫外線の有害性に対する消費者の意識の高まりを受け、紫外線から肌を防御するという効果も求められている。 Powder cosmetics such as powder foundations and white powders are required as base makeup cosmetics to hide skin blots and dull skin problems, resulting in a natural and beautiful finish, but in recent years consumers against the harmful effects of ultraviolet rays In response to the growing awareness of, the effect of protecting the skin from ultraviolet rays is also required.
しかしながら、粉体化粧料は一般に乳化化粧料や油性化粧料に比べ、肌への密着性が劣るため、高い紫外線防御効果を得ることが難しいという問題がある。発明者等が知る限り、少なくとも日本の市場に於いて「SPF50+」と表示されている日焼け止めクリームは散見できるものの、「SPF50+」を表示している粉体化粧料は極めて稀であり、そのようなものは化粧品としての使用性に問題があるのが実態である。(SPF(sun protection factor)は、試料塗布部の紅班形成最小照射量と無塗布部の紅班形成最小照射量との比を表し、「50+」はこの比が51以上であることを表す。) However, since powder cosmetics generally have poor adhesion to skin compared to emulsified cosmetics and oily cosmetics, there is a problem that it is difficult to obtain a high UV protection effect. To the best of the inventors' knowledge, at least in the Japanese market, sunscreen creams labeled “SPF50 +” can be found, but powder cosmetics displaying “SPF50 +” are extremely rare, such as In fact, there is a problem with usability as cosmetics. (SPF (sun protection factor) represents the ratio between the minimum dose of erythema formation at the sample application portion and the minimum dose of erythema formation at the non-application portion, and “50+” indicates that this ratio is 51 or more. .)
従来、日焼け止め化粧品には、有機系の紫外線吸収剤や酸化チタン、酸化亜鉛等の無機微粒子粉体が使用されてきたが、有機系の紫外線吸収剤は皮膚への安全性や使用する系での安定性等に問題があった。無機微粒子粉体の問題としては、安全性に優れるものの、凝集力が高いために皮膚に塗布する際、伸ばしにくく、肌へのなじみが悪く、また、固形粉体化粧料とした場合は、パフへの取れが悪くなるなど化粧品としての使用性に問題があった。 In the past, organic UV absorbers and inorganic fine particle powders such as titanium oxide and zinc oxide have been used in sunscreen cosmetics, but organic UV absorbers are safe for the skin and are used in systems that are used. There was a problem with the stability. The problem with inorganic fine particle powder is that although it is excellent in safety, it is difficult to stretch when applied to the skin due to its high cohesive force, and it does not conform well to the skin. There was a problem in usability as a cosmetic product, such as poor peeling.
無機微粒子粉体の使用性の問題を解決するため、薄片状基質の表面に無機化合物微粒子を担持させ紫外線遮蔽と良好な感触を両立させようという試みが為されている(特許文献1、2)。また、粒子径0.01〜5μmの無機粉末で表面が覆われた球状の樹脂粉末のメーキャップ化粧料への使用が知られている(特許文献3)。しかしながら、これらの複合粉体をそれぞれ粉体化粧料に配合しても、密着性に乏しいため高い紫外線防御効果を得ることは依然として困難であった。 In order to solve the problem of usability of the inorganic fine particle powder, an attempt has been made to achieve both the ultraviolet shielding and good feeling by supporting the inorganic compound fine particles on the surface of the flaky substrate (Patent Documents 1 and 2). . In addition, use of a spherical resin powder whose surface is covered with an inorganic powder having a particle diameter of 0.01 to 5 μm for makeup cosmetics is known (Patent Document 3). However, even if each of these composite powders is blended in a powder cosmetic, it is still difficult to obtain a high UV protection effect due to poor adhesion.
また、微粒子無機粉体で被覆された板状複合粉体と微粒子無機粉体で被覆された球状複合粉体とを粉体化粧料に合わせて配合することは知られておらず、板状複合粉体と球状複合粉体とを合わせて粉体化粧料に使用することで著しく高い紫外線防御効果が相乗的に得られることは全く知られていなかった。 In addition, it is not known that a plate-like composite powder coated with a fine particle inorganic powder and a spherical composite powder coated with a fine particle inorganic powder are mixed in accordance with a powder cosmetic. It has not been known at all that a remarkably high ultraviolet protection effect can be obtained synergistically by using the powder and spherical composite powder together in a powder cosmetic.
本発明は、このような事情を背景になされたものであり、粉体化粧料において、安全性、使用性と紫外線防御効果を向上せしめる技術を提供することを目的とする。 The present invention has been made in view of such circumstances, and an object of the present invention is to provide a technique for improving safety, usability, and UV protection effect in powder cosmetics.
かかる状況を鑑みて、本発明者らは、粉体化粧料において、安全性、使用性および紫外線防御効果を向上せしめる技術を提供すべく鋭意研究努力を重ねた結果、紫外線防御効果の高い微粒子無機粉体で被覆された板状複合粉体と、同じく微粒子無機粉体で被覆された球状複合粉体とを合わせて配合することにより、著しく紫外線防御効果に優れ、安全性、使用性に優れた粉体化粧料が得られることを見出し、本発明を完成するに至った。すなわち、本発明は以下に示す粉体化粧料を提供する。 In view of such a situation, the present inventors have made extensive research efforts to provide a technology for improving safety, usability and UV protection effect in powder cosmetics. By compounding together a plate-like composite powder coated with powder and a spherical composite powder coated with the same fine inorganic particle powder, it is extremely excellent in UV protection, safety and usability. The present inventors have found that a powder cosmetic can be obtained and have completed the present invention. That is, the present invention provides the following powder cosmetics.
次の成分(A)および(B)(各成分の配合量を表す重量%は、粉体化粧料全体の重量に基づく):
(A)粒子径5〜100nmの微粒子酸化チタンおよび/または粒子径5〜400nmの微粒子酸化亜鉛を粒子径1〜50μmの板状粉体に対し、該微粒子酸化チタンおよび/または該微粒子酸化亜鉛:該板状粉体の比率が2:8〜7:3の重量比率で被覆した光輝性を有さない1種または2種以上の板状複合粉体:10〜60重量%、および
(B)粒子径5〜100nmの微粒子酸化チタンおよび/または粒子径5〜400nmの微粒子酸化亜鉛を粒子径1〜50μmの球状粉体に対し、該微粒子酸化チタンおよび/または該微粒子酸化亜鉛:該球状粉体の比率が2:8〜7:3の重量比率で被覆した1種または2種以上の球状複合粉体:4〜50重量%
を含有することを特徴とする粉体化粧料。
The following components (A) and (B) (weight% representing the amount of each component is based on the total weight of the powder cosmetic):
(A) Fine particle titanium oxide having a particle diameter of 5 to 100 nm and / or fine particle zinc oxide having a particle diameter of 5 to 400 nm to a plate-like powder having a particle diameter of 1 to 50 μm , the fine particle titanium oxide and / or the fine particle zinc oxide: One or two or more kinds of plate-like composite powders coated with a weight ratio of the plate- like powders of 2: 8 to 7: 3 and having no glitter: 10 to 60% by weight, and (B) Fine particle titanium oxide and / or fine particle zinc oxide having a particle diameter of 5 to 100 nm and / or fine particle zinc oxide having a particle diameter of 5 to 400 nm and spherical powder having a particle diameter of 1 to 50 μm are used. ratio of 2: 8-7: 1 or more kinds of the spherical composite powder coated with 3 weight ratio: 4-50 wt%
A powder cosmetic comprising:
本発明の粉体化粧料は、好ましくは、上記組成を満足するとともに、次の組成を満足するものである。
次の成分(A1)、(A2)、(B1)および(B2)(各成分の配合量を表す重量%は、粉体化粧料全体の重量に基づく):
(A1)粒子径5〜100nmの微粒子酸化チタンを粒子径1〜50μmの板状粉体に対し、該微粒子酸化チタン:該板状粉体の比率が2:8〜7:3の重量比率で被覆した光輝性を有さない板状複合粉体:3〜40重量%、
(A2)粒子径5〜400nmの微粒子酸化亜鉛を粒子径1〜50μmの板状粉体に対し、該微粒子酸化亜鉛:該板状粉体の比率が2:8〜7:3の重量比率で被覆した光輝性を有さない板状複合粉体:3〜40重量%、
(B1)粒子径5〜100nmの微粒子酸化チタンを粒子径1〜50μmの球状粉体に対し、該微粒子酸化チタン:該球状粉体の比率が2:8〜7:3の重量比率で被覆した球状複合粉体:2〜30重量%、および
(B2)粒子径5〜400nmの微粒子酸化亜鉛を粒子径1〜50μmの球状粉体に対し、該微粒子酸化亜鉛:該球状粉体の比率が2:8〜7:3の重量比率で被覆した球状複合粉体:2〜30重量%
を含有する粉体化粧料。
The powder cosmetic of the present invention preferably satisfies the above composition and also satisfies the following composition.
The following components (A1), (A2), (B1) and (B2) (weight% representing the amount of each component is based on the total weight of the powder cosmetic):
(A1) relative to the plate-like powder having a particle diameter particle size of fine particles of titanium oxide of 5 to 100 nm 1 to 50 [mu] m, fine particles of titanium oxide: said plate ratio of the powder 2: 8-7: 3 weight ratio Covered plate-like composite powder having no glitter: 3 to 40% by weight,
(A2) The fine zinc oxide particles having a particle diameter of 5 to 400 nm and the plate powder having a particle diameter of 1 to 50 μm are in a weight ratio of 2: 8 to 7: 3. Covered plate-like composite powder having no glitter: 3 to 40% by weight,
(B1) Fine particle titanium oxide having a particle size of 5 to 100 nm was coated on a spherical powder having a particle size of 1 to 50 μm at a weight ratio of the fine particle titanium oxide: the spherical powder of 2: 8 to 7: 3. Spherical composite powder: 2 to 30% by weight, and (B2) fine zinc oxide having a particle size of 5 to 400 nm and spherical powder having a particle size of 1 to 50 μm, the ratio of the fine particle zinc oxide to the spherical powder is 2. : Spherical composite powder coated at a weight ratio of 8 to 7: 3: 2 to 30% by weight
Containing powder cosmetics.
本発明によれば、高い紫外線防御効果を有し、安全性、使用性に優れた粉体化粧料を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, it can provide the powder cosmetics which have the high ultraviolet-ray protective effect and were excellent in safety | security and usability.
1.板状複合粉体(A)
本発明の粉体化粧料の(A)成分である板状複合粉体の基質となる板状粉体において、「板状」とは、粉体粒子のアスペクト比(粉体の長径と厚さの比)が5以上のものを指す。板状粉体であれば、特に制限は無く、その具体例としては、雲母、セリサイト、タルク、合成雲母、、板状シリカ、板状チタニア、板状アルミナ、板状硫酸バリウム、窒化ホウ素、板状ガラス粉末等の板状粉体が挙げられる。延展性(肌上でののび)、付着性(肌への付き)、適度な光沢の点から雲母類及びセリサイトが特に好ましい。これらは、1種を単独で用いても、2種以上を組み合わせ用いてもよい。
1. Plate-shaped composite powder (A)
In the plate-like powder serving as the substrate of the plate-like composite powder that is the component (A) of the powder cosmetic of the present invention, “plate-like” refers to the aspect ratio of the powder particles (long diameter and thickness of the powder) Ratio) is 5 or more. If it is a plate-like powder, there is no particular limitation, and specific examples thereof include mica, sericite, talc, synthetic mica, plate-like silica, plate-like titania, plate-like alumina, plate-like barium sulfate, boron nitride, A plate-like powder such as a plate-like glass powder may be mentioned. Mica and sericite are particularly preferable in terms of spreadability (spreading on the skin), adhesion (attachment to the skin), and moderate gloss. These may be used alone or in combination of two or more.
板状粉体の粒子径は1〜50μmであり、1μm未満ではのびが悪く好ましくない。50μmを超えるとざらつきを感じるとともに、ぎらついた光沢感が生じるため好ましくない。特に好ましい粒子径は3〜30μmである。 The particle size of the plate-like powder is 1 to 50 μm. If it exceeds 50 μm, it is not preferable because it feels rough and has a lustrous gloss. A particularly preferable particle size is 3 to 30 μm.
板状複合粉体(A)の調製に使用される微粒子酸化チタンの粒子径は5〜100nmである。粒子径がこの範囲より大きくても、小さくても紫外線吸収効率が低下するので、粒子径をこの範囲に制御する。好ましい粒子径は10〜50nmである。 The particle diameter of the fine particle titanium oxide used for the preparation of the plate-like composite powder (A) is 5 to 100 nm. Even if the particle size is larger or smaller than this range, the ultraviolet absorption efficiency decreases, so the particle size is controlled within this range. A preferable particle diameter is 10 to 50 nm.
板状複合粉体(A)に使用される微粒子酸化亜鉛の粒子径は5〜400nmである。粒子径がこの範囲より大きくても、小さくても紫外線吸収効率が低下するので、粒子径をこの範囲に制御する。好ましい粒子径は10〜300nmである。 The particle diameter of the fine particle zinc oxide used for the plate-like composite powder (A) is 5 to 400 nm. Even if the particle size is larger or smaller than this range, the ultraviolet absorption efficiency decreases, so the particle size is controlled within this range. A preferred particle size is 10 to 300 nm.
微粒子酸化チタンおよび/または微粒子酸化亜鉛の被覆量は、板状粉体に対し、微粒子酸化チタンおよび/または微粒子酸化亜鉛:板状粉体の比率が重量比率で2:8〜7:3である。微粒子酸化チタンおよび/または微粒子酸化亜鉛の比率が2:8より小さいと高い紫外線遮蔽効果が得られず、7:3より大きいと肌に塗布する際、微粒子粉体に由来するきしみ感を感じ、伸びが悪くなる。好ましい重量比率は、微粒子酸化チタン被覆板状複合粉体では微粒子酸化チタン:板状粉体の重量比率が2:8〜6:4であり、また、微粒子酸化亜鉛被覆板状複合粉体では微粒子酸化亜鉛:板状粉体の重量比率が3:7〜7:3である。
The coating amount of fine particle titanium oxide and / or fine particle zinc oxide is such that the ratio of fine particle titanium oxide and / or fine particle zinc oxide: plate-like powder to the plate-like powder is 2: 8 to 7: 3 by weight. . When the ratio of fine particle titanium oxide and / or fine particle zinc oxide is smaller than 2: 8, a high ultraviolet shielding effect cannot be obtained, and when larger than 7: 3, when applied to the skin, a squeaky feeling derived from fine particle powder is felt, Elongation worsens. The preferred weight ratio is such that the weight ratio of fine particle titanium oxide: plate-like powder is 2: 8 to 6: 4 in the case of fine particle titanium oxide-coated plate-like composite powder, and the fine particle amount in fine particle zinc oxide-coated plate-like composite powder The weight ratio of zinc oxide: plate-like powder is from 3: 7 to 7: 3.
本発明の粉体化粧料で用いるの板状複合粉体(A)としては、光輝性を有さないものを用いる。すなわち、微粒子酸化チタンおよび/または微粒子酸化亜鉛による被覆が、真珠光沢顔料に見られるように、緻密な皮膜となる場合は、光輝性が発現するため、ぎらついた仕上がりとなり、また紫外線防御効果も低下するため、紫外線防御化粧料としては好ましくない。 As the plate-like composite powder (A) used in the powder cosmetic of the present invention, those having no glitter are used. That is, when the coating with fine particle titanium oxide and / or fine particle zinc oxide becomes a dense film as seen in pearlescent pigments, it has a brilliant finish, and also has an ultraviolet protection effect. Since it decreases, it is not preferable as a UV protection cosmetic.
2.板状複合粉体(A)の製造
板状複合粉体(A)を製造するには、微粒子酸化チタンおよび/または微粒子酸化亜鉛を板状粉体に被覆することによって、複合化する方法がとられる。この方法としては、湿式法、乾式法のいずれの公知方法も用いることができる。
2. Production of plate-like composite powder (A) To produce plate-like composite powder (A), a method of forming a composite by coating fine plate titanium oxide and / or fine particle zinc oxide on plate-like powder is performed. It is done. As this method, any known method of a wet method and a dry method can be used.
2−1.湿式法による製造
湿式法としては次の方法が挙げられる。
(1)チタン塩又は亜鉛塩の水溶液中に板状粉体を懸濁させ、チタン塩又は亜鉛塩を加水分解することにより、チタン又は亜鉛の水酸化物または酸化物粒子を板状粉体表面に析出させ、ろ過、水洗、乾燥または焼成する。板状粉体に酸化チタン粒子を被覆する場合は、例えば特許文献2に記載されているような方法を用いることができる。前述のように、酸化チタンおよび/または酸化亜鉛による被覆が、真珠光沢顔料に見られるように、緻密な皮膜となるものは、光輝性が発現するため、使用を避けるべきである。
2-1. Manufacture by a wet method The following method is mentioned as a wet method.
(1) A plate-like powder is suspended in an aqueous solution of a titanium salt or a zinc salt, and the titanium or zinc hydroxide is hydrolyzed to form titanium or zinc hydroxide or oxide particles on the surface of the plate-like powder. And then filtered, washed with water, dried or fired. When coating plate-like powder with titanium oxide particles, for example, a method as described in Patent Document 2 can be used. As described above, when a coating with titanium oxide and / or zinc oxide becomes a dense film as seen in pearlescent pigments, it should be avoided to use since it exhibits glitter.
(2)板状粉体と微粒子酸化チタンまたは微粒子酸化亜鉛を有機溶媒および/または水からなる分散媒に分散させ、微粒子粉体と板状粉体の静電気的相互作用を利用して板状粉体表面に微粒子粉体を被覆することもできる(特開平9−132514、特開2003−212721)。
(3)超臨界二酸化炭素の存在下で板状粉体を微粒子粉体で被覆する方法(特開2004−238337)を採用することもできる。
(2) Plate-like powder and fine-particle titanium oxide or fine-particle zinc oxide are dispersed in a dispersion medium composed of an organic solvent and / or water, and the plate-like powder is utilized by utilizing electrostatic interaction between the fine-particle powder and the plate-like powder. The body surface can be coated with fine particle powder (Japanese Patent Laid-Open Nos. 9-132514 and 2003-212721).
(3) A method of coating a plate-like powder with fine particle powder in the presence of supercritical carbon dioxide (Japanese Patent Application Laid-Open No. 2004-238337) can also be employed.
2−2.乾式法による製造
乾式法としては、メカノケミカルによる方法(例えば特開平5−214257)を採用することができる。
2-2. Production by dry method As the dry method, a mechanochemical method (for example, JP-A-5-214257) can be employed.
チタンまたは亜鉛塩の加水分解により微粒子粉体を析出させる場合以外は、市販の微粒子粉体を用いることができる。市販の微粒子酸化チタンとしては、MT−100SA、MT−05、MT−500B、MT−500H、MT−500HSA(テイカ株式会社製)、TTO−51(A)、TTO−55(A)、TTO−55(B)、TTO−F1、TTO−S1(石原産業株式会社製)等が好適に利用できる。市販の微粒子酸化亜鉛としては、MZ−300、MZ−500、MZ−700(テイカ株式会社製)、微細亜鉛華、FINEX−25、FINEX−50、FINEX−75(堺化学工業株式会社製)等が好適に利用できる。 Commercially available fine particle powder can be used except when the fine particle powder is precipitated by hydrolysis of titanium or zinc salt. Examples of commercially available fine particle titanium oxide include MT-100SA, MT-05, MT-500B, MT-500H, MT-500HSA (manufactured by Teika Co., Ltd.), TTO-51 (A), TTO-55 (A), and TTO-. 55 (B), TTO-F1, TTO-S1 (manufactured by Ishihara Sangyo Co., Ltd.) and the like can be suitably used. Examples of commercially available fine particle zinc oxide include MZ-300, MZ-500, MZ-700 (manufactured by Teika Co., Ltd.), fine zinc white, FINEX-25, FINEX-50, FINEX-75 (manufactured by Sakai Chemical Industry Co., Ltd.), etc. Can be suitably used.
板状複合粉体(A)は、通常化粧料用粉体で知られている表面疎水化処理をすることが好ましい。かかる表面疎水化処理としては、例えば、メチルハイドロジェンポリシロキサン、(ジメチコン/メチコン)コポリマー等のシリコーンによる焼付け処理、ステアリン酸等の脂肪酸処理、ステアリン酸アルミニウムやステアリン酸亜鉛等の脂肪酸金属石ケン処理、アシル化アミノ酸(塩)処理、アシル化アミノ酸(塩)と脂肪酸(塩)の混合処理であるリポアミノ酸処理、パーフルオロアルキルリン酸塩等のフッ素処理、シリル化処理、セバシン酸イソステアリル等の酸性エステル処理等公知の表面処理を使用することができる。中でも、使用性、化粧持続性の面から脂肪酸金属石ケン処理、シリコーン処理が特に好ましい。 The plate-like composite powder (A) is preferably subjected to a surface hydrophobization treatment that is generally known for cosmetic powders. Examples of such surface hydrophobing treatment include baking treatment with silicone such as methyl hydrogen polysiloxane and (dimethicone / methicone) copolymer, fatty acid treatment such as stearic acid, and fatty acid metal soap treatment such as aluminum stearate and zinc stearate. , Acylated amino acid (salt) treatment, lipoamino acid treatment that is a mixed treatment of acylated amino acid (salt) and fatty acid (salt), fluorine treatment such as perfluoroalkyl phosphate, silylation treatment, isostearyl sebacate, etc. Known surface treatments such as acidic ester treatment can be used. Of these, fatty acid metal soap treatment and silicone treatment are particularly preferred from the viewpoints of usability and makeup sustainability.
疎水化表面処理は、予め複合化前に、微粒子粉体および/または板状粉体に施してもよい。表面を覆う微粒子粉体が疎水化されていることにより充分な化粧持続性効果が得られる。 The hydrophobized surface treatment may be applied to the fine particle powder and / or the plate-like powder before compounding in advance. A sufficient makeup sustaining effect can be obtained by making the fine particle powder covering the surface hydrophobic.
疎水化表面処理が施された微粒子粉体としては、市販品を使用することもできる。そのような微粒子酸化チタンとしては、MT−100TV(ステアリン酸アルミニウム処理)、MT−01(ステアリン酸アルミニウム処理)、MT−500T(ステアリン酸アルミニウム処理)、MT−500SAS(ジメチコン/メチコンコポリマー処理)(テイカ株式会社製)等が好適に利用できる。疎水化表面処理が施された微粒子酸化亜鉛としては、MZ−303S(メチコン処理)、MZ−303M(ジメチコン処理)、MZ−503S(メチコン処理)、MZ−503M(ジメチコン処理)(テイカ株式会社製)等が好適に利用できる。 Commercially available products can also be used as the fine particle powder subjected to the hydrophobic surface treatment. Examples of such fine particle titanium oxide include MT-100TV (treated with aluminum stearate), MT-01 (treated with aluminum stearate), MT-500T (treated with aluminum stearate), MT-500SAS (treated with dimethicone / methicone copolymer) ( (Taika Co., Ltd.) etc. can be suitably used. As the fine particle zinc oxide subjected to the hydrophobic surface treatment, MZ-303S (methicone treatment), MZ-303M (dimethicone treatment), MZ-503S (methicone treatment), MZ-503M (dimethicone treatment) (manufactured by Teika Co., Ltd.) Etc.) can be suitably used.
3.板状複合粉体(A)の特性
板状複合粉体(A)においては、微粒子粉体が板状粉体に充分強固に付着している必要がある。付着が不充分であれば、化粧料の製剤中または化粧料を皮膚に適用する際、微粒子粉体として挙動するため塗布の際の摩擦抵抗が大きくなり、伸びが悪く使用性が低下する。そのため、板状複合粉体(A)は、平均摩擦係数(MIU値)が0.6以下であることが好ましい。より好ましくはMIU値が微粒子酸化チタン被覆板状複合粉体にあっては、0.5以下、微粒子酸化亜鉛被覆板状複合粉体にあっては、0.4以下である。
3. Characteristics of the plate-like composite powder (A) In the plate-like composite powder (A), the fine particle powder needs to adhere to the plate-like powder sufficiently firmly. If the adhesion is insufficient, when it is applied to the skin in cosmetic preparations or when the cosmetic is applied to the skin, it behaves as a fine particle powder, resulting in increased frictional resistance during application, poor elongation, and reduced usability. Therefore, the plate-like composite powder (A) preferably has an average friction coefficient (MIU value) of 0.6 or less. More preferably, the MIU value is 0.5 or less for the fine particle titanium oxide-coated plate-like composite powder, and 0.4 or less for the fine particle zinc oxide-coated plate-like composite powder.
平均摩擦係数の測定はカトーテック(株)製摩擦感テスタ−KES−SEを使用し、測定する粉末を人工皮革(出光テクノファイン株式会社製PBZ13001)上に0.5mg/cm2となるように均一に塗り広げ、荷重50gの条件で求めることができる。 The average friction coefficient is measured using Kato Tech Co., Ltd. friction tester-KES-SE, and the powder to be measured is 0.5 mg / cm 2 on artificial leather (PBZ13001 made by Idemitsu Techno Fine Co., Ltd.). It can be uniformly applied and obtained under the condition of a load of 50 g.
板状複合粉体(A)の一つである微粒子酸化チタン被覆板状複合粉体は、サンプル塗布プレートに0.8mg/cm2で塗布した時のin vitro SPFが4以上であることが好ましい。また、板状複合粉体(A)の他の一つである微粒子酸化亜鉛被覆板状複合粉体は、上記と同条件で測定したin vitro SPFが2以上であることが好ましい。 The fine particle titanium oxide-coated plate-like composite powder that is one of the plate-like composite powders (A) preferably has an in vitro SPF of 4 or more when applied to a sample application plate at 0.8 mg / cm 2. . In addition, the fine zinc oxide-coated plate-like composite powder which is another one of the plate-like composite powder (A) preferably has an in vitro SPF of 2 or more measured under the same conditions as described above.
in vitro SPFは、例えば、Labshere社製SPF Analyzer UV−1000Sを使用して測定することができる。但し、サンプル塗布プレートとしては、資生堂医理化テクノロジー社製PA−1を使用する。サンプル塗布プレートPA−1は、ヒトの皮膚形状に類似した擬似皮溝を有するプレートであって、in vivoのSPF測定に近い値が得られるとされている(非特許文献 石窪他 J.Soc.Cosmet.Chem.Japan Vol.37,No.1 10−15(2003)「新規In Vitro紫外線防御評価法の開発」)。サンプル塗布プレートに所定量を指で均一に塗布し、10回測定を行い、平均のSPF値を求める。 In vitro SPF can be measured, for example, using SPF Analyzer UV-1000S manufactured by Labshere. However, PA-1 manufactured by Shiseido Medical Rika Technology Co., Ltd. is used as the sample application plate. The sample application plate PA-1 is a plate having a pseudo skin groove similar to a human skin shape, and it is said that a value close to in vivo SPF measurement is obtained (Non-Patent Document Ishikubo et al., J. Soc Cosmet.Chem.Japan Vol.37, No.1 10-15 (2003) "Development of a new in vitro UV protection evaluation method"). A predetermined amount is evenly applied to the sample application plate with a finger, measured 10 times, and an average SPF value is obtained.
板状複合粉体の配合量(A)は、粉体化粧料全体に対して10〜60重量%である。10重量%未満では充分な紫外線防御効果が得られず、60重量%を超えると微粒子粉体量が増えるため、伸びが悪くなり好ましくない。より好ましい配合量は15〜45重量%である。 The compounding amount (A) of the plate-like composite powder is 10 to 60% by weight based on the whole powder cosmetic. If it is less than 10% by weight, a sufficient UV protection effect cannot be obtained. A more preferable blending amount is 15 to 45% by weight.
4.球状複合粉体(B)
本発明の粉体化粧料の(B)成分である球状複合粉体の基質となる球状粉体において、「球状」とは、粉体粒子が球状であることを指し、略球状であれば良いが、使用性の点から真球状に近いものが好ましい。球状粉体であれば、特に制限は無く、無機粒子、有機粒子が用いられる。無機球状粉体の具体例としては無水ケイ酸、炭酸カルシウム、ケイ酸カルシウム等が挙げられる。有機球状粉体の具体例としては、ナイロン、ポリエチレン、ポリプロピレン、ポリエステル、ポリスチレン、ポリウレタン、スチレン−アクリル共重合体、ポリメチルメタクリレート、セルロース、ポリオレフィン、ポリテトラフルオロエチレン、シリコーン粉末等が挙げられる。これらの中で使用性・感触の点から有機球状粉体が好ましく、中でもナイロン、架橋タイプのポリメチルメタクリレート、ポリメチルシルセスキオキサン、ポリウレタン、シリコーンエラストマー粉体が特に好ましい。これらは、1種を単独で用いても、2種以上を組み合わせ用いてもよい。
4). Spherical composite powder (B)
In the spherical powder that is the substrate of the spherical composite powder that is the component (B) of the powder cosmetic of the present invention, “spherical” means that the powder particles are spherical and may be substantially spherical. However, those close to true spheres are preferable from the viewpoint of usability. If it is spherical powder, there is no restriction | limiting in particular, An inorganic particle and an organic particle are used. Specific examples of the inorganic spherical powder include anhydrous silicic acid, calcium carbonate, calcium silicate and the like. Specific examples of the organic spherical powder include nylon, polyethylene, polypropylene, polyester, polystyrene, polyurethane, styrene-acrylic copolymer, polymethyl methacrylate, cellulose, polyolefin, polytetrafluoroethylene, and silicone powder. Of these, organic spherical powders are preferable from the viewpoint of usability and feel, and among these, nylon, cross-linked polymethyl methacrylate, polymethylsilsesquioxane, polyurethane, and silicone elastomer powder are particularly preferable. These may be used alone or in combination of two or more.
球状複合粉体(B)に使用される球状粉体の粒子径は1〜50μmである。1μm未満では伸びが悪く好ましくない。50μmを超えるとざらつきを感じるとともに、付着性が減少するため好ましくない。好ましい粒子径は3〜30μmである。 The particle diameter of the spherical powder used for the spherical composite powder (B) is 1 to 50 μm. If it is less than 1 μm, the elongation is poor, which is not preferable. When it exceeds 50 μm, it is not preferable because it feels rough and adhesion decreases. A preferable particle diameter is 3 to 30 μm.
球状複合粉体(B)に使用される微粒子酸化チタンの粒子径は5〜100nmである。微粒子酸化チタンの粒子径がこの範囲より大きくても、小さくても紫外線吸収効率が低下するので、粒子径をこの範囲に制御する。好ましい粒子径は10〜50nmである。 The particle diameter of the fine particle titanium oxide used for the spherical composite powder (B) is 5 to 100 nm. Even if the particle diameter of the fine particle titanium oxide is larger or smaller than this range, the ultraviolet absorption efficiency decreases, so the particle diameter is controlled within this range. A preferable particle diameter is 10 to 50 nm.
球状複合粉体(B)に使用される微粒子酸化亜鉛の粒子径は5〜400nmである。微粒子酸化亜鉛の粒子径がこの範囲より大きくても、小さくても紫外線吸収効率が低下するので、粒子径をこの範囲に制御する。好ましい粒子径は10〜300nmである。 The particle diameter of the fine particle zinc oxide used for the spherical composite powder (B) is 5 to 400 nm. Even if the particle diameter of the fine zinc oxide is larger or smaller than this range, the ultraviolet absorption efficiency decreases, so the particle diameter is controlled within this range. A preferred particle size is 10 to 300 nm.
チタンまたは亜鉛塩の加水分解により微粒子粉体を析出させる場合以外は、市販の微粒子粉体を用いることができる。市販の微粒子酸化チタンとしては、MT−100SA、MT−05、MT−500B、MT−500H、MT−500HSA(テイカ株式会社製)、TTO−51(A)、TTO−55(A)、TTO−55(B)、TTO−F1、TTO−S1(石原産業株式会社製)等が好適に利用できる。市販の微粒子酸化亜鉛としては、MZ−300、MZ−500、MZ−700(テイカ株式会社製)、微細亜鉛華、FINEX−25、FINEX−50、FINEX−75(堺化学工業株式会社製)等が好適に利用できる。 Commercially available fine particle powder can be used except when the fine particle powder is precipitated by hydrolysis of titanium or zinc salt. Examples of commercially available fine particle titanium oxide include MT-100SA, MT-05, MT-500B, MT-500H, MT-500HSA (manufactured by Teika Co., Ltd.), TTO-51 (A), TTO-55 (A), and TTO-. 55 (B), TTO-F1, TTO-S1 (manufactured by Ishihara Sangyo Co., Ltd.) and the like can be suitably used. Examples of commercially available fine particle zinc oxide include MZ-300, MZ-500, MZ-700 (manufactured by Teika Co., Ltd.), fine zinc white, FINEX-25, FINEX-50, FINEX-75 (manufactured by Sakai Chemical Industry Co., Ltd.), etc. Can be suitably used.
微粒子酸化チタンおよび/または微粒子酸化亜鉛の被覆量は、球状粉体に対し、該微粒子酸化チタンおよび/または該微粒子酸化亜鉛:該球状粉体の重量比率が2:8〜7:3である。微粒子酸化チタンおよび/または微粒子酸化亜鉛の重量比率が2:8より小さいと高い紫外線遮蔽効果が得られず、7:3より大きいと肌に塗布する際、微粒子粉体に由来するきしみ感を感じ、伸びが悪くなる。好ましい重量比率は、微粒子酸化チタンおよび/または微粒子酸化亜鉛:球状粉体の重量比率が3:7〜6:4である。
The coating amount of fine particle titanium oxide and / or fine particle zinc oxide is such that the weight ratio of fine particle titanium oxide and / or fine particle zinc oxide: spherical powder is 2: 8 to 7: 3 with respect to the spherical powder. When the weight ratio of fine particle titanium oxide and / or fine particle zinc oxide is smaller than 2: 8, a high ultraviolet shielding effect cannot be obtained, and when larger than 7: 3, a squeaky feeling derived from fine particle powder is felt when applied to the skin. , The elongation becomes worse. A preferred weight ratio is such that the weight ratio of fine particle titanium oxide and / or fine particle zinc oxide: spherical powder is 3: 7 to 6: 4.
5.球状複合粉体(B)の製造
球状複合粉体(B)を製造するには、微粒子酸化チタンおよび/または微粒子酸化亜鉛を球状粉体に被覆することによって、複合化する方法がとられる。この方法としては、湿式法、乾式法のいずれの公知方法も用いることができる。湿式法および乾式法としては、前記2−1および2−2で説明したのと同様な方法が挙げられる。中でも、メカノケミカルによる乾式複合化法を用いることが、使用性、紫外線防御効果の点から好ましい。
5. Production of Spherical Composite Powder (B) In order to produce the spherical composite powder (B), a method is adopted in which a spherical powder is coated with fine particle titanium oxide and / or fine particle zinc oxide to form a composite. As this method, any known method of a wet method and a dry method can be used. Examples of the wet method and the dry method include the same methods as described in 2-1 and 2-2. Among these, the mechanochemical dry compounding method is preferable from the viewpoints of usability and UV protection effect.
メカノケミカルによる乾式複合化の方法としては、特許文献3に示される各種ボールミル、ポットミル、乳鉢、擂潰機、アトライタ等の混合装置を用いることができ、また、高速ジェット気流粉砕機、ハイブリタイザー、メカノフュージョン等の周知の複合化機器を使用することもできる。 As a method of dry compounding by mechanochemical, various ball mills, pot mills, mortars, grinders, attritors and the like shown in Patent Document 3 can be used, and a high-speed jet airflow crusher, a hybridizer, A well-known compounding device such as mechanofusion can also be used.
球状複合粉体(B)は、通常化粧料用粉体で知られている表面疎水化処理をすることが好ましい。かかる表面処理としては、例えば、メチルハイドロジェンポリシロキサン、(ジメチコン/メチコン)コポリマー等のシリコーンによる焼付け処理、ステアリン酸等の脂肪酸処理、ステアリン酸アルミニウムやステアリン酸亜鉛等の脂肪酸金属石ケン処理、アシル化アミノ酸処理、アシル化アミノ酸(塩)と脂肪酸(塩)の混合処理であるリポアミノ酸処理、パーフルオロアルキルリン酸塩等のフッ素処理、シリル化処理、セバシン酸イソステアリル等の酸性エステル処理等公知の表面処理を使用することができる。中でも、使用性、化粧持続性の面から脂肪酸金属石ケン処理、シリコーン処理が特に好ましい。 The spherical composite powder (B) is preferably subjected to a surface hydrophobization treatment that is generally known for cosmetic powders. Examples of such surface treatment include baking treatment with silicone such as methyl hydrogen polysiloxane and (dimethicone / methicone) copolymer, fatty acid treatment such as stearic acid, fatty acid metal soap treatment such as aluminum stearate and zinc stearate, acyl Amino acid treatment, lipoamino acid treatment that is a mixed treatment of acylated amino acid (salt) and fatty acid (salt), fluorine treatment such as perfluoroalkyl phosphate, silylation treatment, acidic ester treatment such as isostearyl sebacate, etc. Surface treatment can be used. Of these, fatty acid metal soap treatment and silicone treatment are particularly preferred from the viewpoints of usability and makeup sustainability.
疎水化表面処理は、予め複合化前に、微粒子粉体および/または球状粉体に施してもよい。表面を覆う微粒子粉体が疎水化されていることにより充分な化粧持続性効果が得られる。 The hydrophobized surface treatment may be applied to the fine particle powder and / or the spherical powder in advance before being combined. A sufficient makeup sustaining effect can be obtained by making the fine particle powder covering the surface hydrophobic.
疎水化表面処理が施された微粒子粉体としては、市販品を使用することもできる。そのような微粒子酸化チタンとしては、MT−100TV(ステアリン酸アルミニウム処理)、MT−01(ステアリン酸アルミニウム処理)、MT−500T(ステアリン酸アルミニウム処理)、MT−500SAS(ジメチコン/メチコンコポリマー処理)(テイカ株式会社製)等が好適に利用できる。疎水化表面処理が施された微粒子酸化亜鉛としては、MZ−303S(メチコン処理)、MZ−303M(ジメチコン処理)、MZ−503S(メチコン処理)、MZ−503M(ジメチコン処理)(テイカ株式会社製)等が好適に利用できる。 Commercially available products can also be used as the fine particle powder subjected to the hydrophobic surface treatment. Examples of such fine particle titanium oxide include MT-100TV (treated with aluminum stearate), MT-01 (treated with aluminum stearate), MT-500T (treated with aluminum stearate), MT-500SAS (treated with dimethicone / methicone copolymer) ( (Taika Co., Ltd.) etc. can be suitably used. As the fine particle zinc oxide subjected to the hydrophobic surface treatment, MZ-303S (methicone treatment), MZ-303M (dimethicone treatment), MZ-503S (methicone treatment), MZ-503M (dimethicone treatment) (manufactured by Teika Co., Ltd.) Etc.) can be suitably used.
6.球状複合粉体(B)の特性
球状複合粉体(B)においては、微粒子粉体が球状粉体に充分強固に付着している必要がある。付着が不充分であれば、化粧料の製剤中または化粧料を皮膚に適用する際、微粒子粉体として挙動するため塗布の際の摩擦抵抗が大きくなり、伸びが悪く使用性が低下する。そのため、球状複合粉体(B)は、平均摩擦係数(MIU値)が0.3以下であることが好ましい。より好ましくはMIU値が0.28以下である。平均摩擦係数の測定法は、板状複合粉体(A)について記載したとおりである。
6). Characteristics of the spherical composite powder (B) In the spherical composite powder (B), the fine particle powder needs to adhere to the spherical powder sufficiently firmly. If the adhesion is insufficient, when it is applied to the skin in cosmetic preparations or when the cosmetic is applied to the skin, it behaves as a fine particle powder, resulting in increased frictional resistance during application, poor elongation, and reduced usability. Therefore, the spherical composite powder (B) preferably has an average friction coefficient (MIU value) of 0.3 or less. More preferably, the MIU value is 0.28 or less. The method for measuring the average friction coefficient is as described for the plate-like composite powder (A).
球状複合粉体(B)の一つである微粒子酸化チタン被覆球状複合粉体は、サンプル塗布プレートに0.8mg/cm2で塗布した時のin vitro SPFが4以上であることが好ましい。また、球状複合粉体(B)の他の一つである微粒子酸化亜鉛被覆球状複合粉体は上記と同条件で測定したin vitro SPFが3以上であることが好ましい。in vitro SPFの測定法は、板状複合粉体(A)について記載したとおりである。 The fine titanium oxide-coated spherical composite powder that is one of the spherical composite powders (B) preferably has an in vitro SPF of 4 or more when applied to a sample coating plate at 0.8 mg / cm 2 . The fine zinc oxide-coated spherical composite powder which is another spherical composite powder (B) preferably has an in vitro SPF of 3 or more measured under the same conditions as described above. The measuring method of in vitro SPF is as described for the plate-like composite powder (A).
球状複合粉体の配合量(B)は、粉体化粧料全体に対して4〜50重量%である。4重量%未満では充分な紫外線防御効果が得られず、50重量%を超えると微粒子粉体量が増えるため、伸びが悪くなり好ましくない。より好ましい配合量は8〜40重量%である。 The blending amount (B) of the spherical composite powder is 4 to 50% by weight with respect to the whole powder cosmetic. If the amount is less than 4% by weight, a sufficient UV protection effect cannot be obtained. A more preferable blending amount is 8 to 40% by weight.
7.粉体化粧料の組成
本発明の粉体化粧料において、板状複合粉体(A)および球状複合粉体(B)の配合量は、それぞれ、粉体化粧料の重量に基づいて、10〜60重量%および4〜50重量%である。
また、板状複合粉体(A)と球状複合粉体(B)の配合比率は、重量比〔(A):(B)〕で9:1〜3:7であることが好ましい。
7). Composition of powder cosmetic In the powder cosmetic of the present invention, the compounding amounts of the plate-like composite powder (A) and the spherical composite powder (B) are 10 to 10 based on the weight of the powder cosmetic, respectively. 60% by weight and 4-50% by weight.
The mixing ratio of the plate-like composite powder (A) a spherical composite powder (B) has a weight ratio [(A) :( B)] in 9: 1 to 3: is preferably 7.
板状複合粉体(A)のみ、あるいは球状複合粉体のみ(B)からなる粉体化粧料では、凹凸構造のある皮膚表面を均一に覆うことは難しく、高い紫外線防御効果を得ることができない。すなわち、板状複合粉体は主に肌の凸部である皮丘に付着しやすく、皮溝部分での微粒子粉体の存在が少なく、逆に球状複合粉体は主に肌の凹部である皮溝に付着しやすいためである。より好ましい板状複合粉体(A)と球状複合粉体(B)の配合比率は、重量比〔(A):(B)〕で8:2〜4:6である。
With a powder cosmetic comprising only the plate-like composite powder (A) or only the spherical composite powder (B), it is difficult to uniformly cover the skin surface with an uneven structure, and a high UV protection effect cannot be obtained. . That is, the plate-like composite powder tends to adhere mainly to the skin ridges, and the presence of fine particle powder in the skin groove is small, whereas the spherical composite powder is mainly skin depressions. This is because it easily adheres to the skin groove. A more preferable mixing ratio of the plate-like composite powder (A) and the spherical composite powder (B) is 8: 2 to 4: 6 in a weight ratio [(A) :( B)] .
本発明の粉体化粧料において、より高いSPF値およびPA(Protection Grade of UVA)値を得るためには、上記組成を満足するとともに、次の組成を満足する粉体化粧料であることが好ましい。 In the powder cosmetic of the present invention, in order to obtain a higher SPF value and PA (Protection Grade of UVA) value, it is preferable that the powder cosmetic satisfy the above composition and the following composition. .
次の成分(A1)、(A2)、(B1)および(B2)(各成分の配合量を表す重量%は、粉体化粧料全体の重量に基づく):
(A1)粒子径5〜100nmの微粒子酸化チタンを粒子径1〜50μmの板状粉体に対し、該微粒子酸化チタン:該板状粉体の比率が2:8〜7:3の重量比率で被覆した光輝性を有さない板状複合粉体:3〜40重量%、好ましくは7〜40重量%、
(A2)粒子径5〜400nmの微粒子酸化亜鉛を粒子径1〜50μmの板状粉体に対し、該微粒子酸化亜鉛:該板状粉体の比率が2:8〜7:3の重量比率で被覆した光輝性を有さない板状複合粉体:3〜40重量%、好ましくは7〜40重量%、
(B1)粒子径5〜100nmの微粒子酸化チタンを粒子径1〜50μmの球状粉体に対し、該微粒子酸化チタン:該球状粉体の比率が2:8〜7:3の重量比率で被覆した球状複合粉体:2〜30重量%、好ましくは5〜30重量%、および
(B2)粒子径5〜400nmの微粒子酸化亜鉛を粒子径1〜50μmの球状粉体に対し、該微粒子酸化亜鉛:該球状粉体の比率が2:8〜7:3の重量比率で被覆した球状複合粉体:2〜30重量%、好ましくは3〜30重量%、
を含有する粉体化粧料。
The following components (A1), (A2), (B1) and (B2) (weight% representing the amount of each component is based on the total weight of the powder cosmetic):
(A1) relative to the plate-like powder having a particle diameter particle size of fine particles of titanium oxide of 5 to 100 nm 1 to 50 [mu] m, fine particles of titanium oxide: said plate ratio of the powder 2: 8-7: 3 weight ratio Coated plate-like composite powder having no glitter: 3 to 40% by weight, preferably 7 to 40% by weight,
(A2) The fine zinc oxide particles having a particle diameter of 5 to 400 nm and the plate powder having a particle diameter of 1 to 50 μm are in a weight ratio of 2: 8 to 7: 3. Coated plate-like composite powder having no glitter: 3 to 40% by weight, preferably 7 to 40% by weight,
(B1) Fine particle titanium oxide having a particle size of 5 to 100 nm was coated on a spherical powder having a particle size of 1 to 50 μm at a weight ratio of the fine particle titanium oxide: the spherical powder of 2: 8 to 7: 3. spherical composite powder: 2-30 wt%, preferably 5 to 30 wt%, and (B2) a zinc oxide fine particles having a particle diameter 5~400nm to spherical powder of particle size 1 to 50 [mu] m, the particulate zinc oxide: Spherical composite powder coated with a spherical powder ratio of 2: 8 to 7: 3: 2 to 30% by weight, preferably 3 to 30% by weight,
Containing powder cosmetics.
8.粉体化粧料の他の成分
本発明の粉体化粧料では、前記複合粉体(A1)、(A2)、(B1)、(B2)以外の粉体成分を併用することが好ましい。併用される成分には、種々の無機粉体および有機粉体が挙げられる。
併用することができる無機粉体としては、酸化チタン、酸化亜鉛、ベンガラ、黄酸化鉄、黒酸化鉄、群青、紺青、酸化セリウム、タルク、白雲母、合成雲母、金雲母、黒雲母、合成フッ素金雲母、雲母チタン、雲母状酸化鉄、セリサイト、ゼオライト、カオリン、ベントナイト、クレー、ケイ酸、無水ケイ酸、ケイ酸マグネシウム、ケイ酸アルミニウムマグネシウム、ケイ酸カルシウム、硫酸バリウム、硫酸マグネシウム、硫酸カルシウム、炭酸カルシウム、炭酸マグネシウム、チッ化ホウ素、オキシ塩化ビスマス、アルミナ、酸化ジルコニウム、酸化マグネシウム、酸化クロム、カラミン、ヒドロキシアパタイト、窒化ホウ素およびこれらの複合体等が挙げられる。これらの中でも窒化ホウ素、セリサイト、合成フッ素金雲母は、使用性が優れ、好ましい。これらの無機粉体は、さらに、使用性、化粧持続性の点から表面疎水化処理をすることが好ましい。かかる表面処理としては、例えば、メチルハイドロジェンポリシロキサン、(ジメチコン/メチコン)コポリマー等のシリコーンによる焼付け処理、ステアリン酸等の脂肪酸処理、ステアリン酸アルミニウムやステアリン酸亜鉛等の脂肪酸金属石ケン処理、アシル化アミノ酸処理、アシル化アミノ酸(塩)と脂肪酸(塩)の混合処理であるリポアミノ酸処理、パーフルオロアルキルリン酸塩等のフッ素処理、シリル化処理、セバシン酸イソステアリル等の酸性エステル処理等公知の表面処理を使用することができる。特に、使用性、化粧持続性の面から、酸性エステル処理、アミノ酸処理、リポアミノ酸処理が特に好ましい。また、体質顔料としてセバシン酸イソステアリル処理セリサイトを、粉体化粧料重量に基づき5〜50重量%、前記板状複合粉体(A)及び球状複合粉体(B)と併用することが、使用性、付着性の点から特に好ましい。
8). Other components of powder cosmetic In the powder cosmetic of the present invention, it is preferable to use a powder component other than the composite powders (A1), (A2), (B1), and (B2). Examples of components used in combination include various inorganic powders and organic powders.
Inorganic powders that can be used in combination include titanium oxide, zinc oxide, bengara, yellow iron oxide, black iron oxide, ultramarine, bitumen, cerium oxide, talc, muscovite, synthetic mica, phlogopite, biotite, synthetic fluorine. Phlogopite, titanium mica, mica-like iron oxide, sericite, zeolite, kaolin, bentonite, clay, silicic acid, anhydrous silicic acid, magnesium silicate, magnesium aluminum silicate, calcium silicate, barium sulfate, magnesium sulfate, calcium sulfate , Calcium carbonate, magnesium carbonate, boron nitride, bismuth oxychloride, alumina, zirconium oxide, magnesium oxide, chromium oxide, calamine, hydroxyapatite, boron nitride, and composites thereof. Among these, boron nitride, sericite, and synthetic fluorine phlogopite are preferable because of their excellent usability. These inorganic powders are preferably subjected to a surface hydrophobization treatment from the viewpoints of usability and makeup sustainability. Examples of such surface treatment include baking treatment with silicone such as methyl hydrogen polysiloxane and (dimethicone / methicone) copolymer, fatty acid treatment such as stearic acid, fatty acid metal soap treatment such as aluminum stearate and zinc stearate, acyl Amino acid treatment, lipoamino acid treatment that is a mixed treatment of acylated amino acid (salt) and fatty acid (salt), fluorine treatment such as perfluoroalkyl phosphate, silylation treatment, acidic ester treatment such as isostearyl sebacate, etc. Surface treatment can be used. In particular, acidic ester treatment, amino acid treatment, and lipoamino acid treatment are particularly preferred from the viewpoints of usability and makeup sustainability. In addition, isostearyl sebacate-treated sericite as an extender is used in combination with 5 to 50% by weight based on the weight of the powder cosmetic, the plate-like composite powder (A) and the spherical composite powder (B). Particularly preferred from the viewpoint of usability and adhesion.
同じく併用することができる有機粉体としては、シリコーン粉末、シリコーン弾性粉末、ポリウレタン粉末、セルロース粉末、ナイロン粉末、シルク粉末、PMMA粉末、スターチ、ポリエチレン粉末、ポリスチレン粉末、カーボンブラック、タール色素、天然色素、ステアリン酸亜鉛等の金属石鹸等およびこれらの複合体等が挙げられる。使用性の点からシリコーン弾性粉末、ポリウレタン粉末等のエラストマー粉体を好適に使用することができ、その配合量は、粉体化粧料重量に基づき1〜10重量%が好ましい。 Similarly, organic powders that can be used in combination include silicone powder, silicone elastic powder, polyurethane powder, cellulose powder, nylon powder, silk powder, PMMA powder, starch, polyethylene powder, polystyrene powder, carbon black, tar pigment, and natural pigment. Metal soaps such as zinc stearate, and composites thereof. Elastomer powders such as silicone elastic powder and polyurethane powder can be suitably used from the viewpoint of usability, and the blending amount is preferably 1 to 10% by weight based on the weight of the powder cosmetic.
本発明の粉体化粧料には、通常化粧料で使用される油性成分を配合することができる。かかる油性成分としては、例えば、マカデミアナッツ油、アボガド油、トウモロコシ油、オリーブ油、ナタネ油、ゴマ油、ヒマシ油、サフラワー油、綿実油、ホホバ油、ヤシ油、パーム油、液状ラノリン、硬化ヤシ油、硬化油、モクロウ、硬化ヒマシ油、ミツロウ、キャンデリラロウ、カルナウバロウ、イボタロウ、ラノリン、還元ラノリン、硬質ラノリン、ホホバロウ等のオイル、ワックス類、流動パラフィン、スクワラン、プリスタン、オゾケライト、パラフィン、セレシン、ワセリン、マイクロクリスタリンワックス等の炭化水素類、オレイン酸、イソステアリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、ウンデシレン酸等の高級脂肪酸類、セチルアルコール、ステアリルアルコール、イソステアリルアルコール、ベヘニルアルコール、オクチルドデカノール、ミリスチルアルコール、セトステアリルアルコール等の高級アルコール等、イソオクタン酸セチル、ミリスチン酸イソプロピル、イソステアリン酸ヘキシルデシル、アジピン酸ジイソプロピル、セバシン酸ジ−2−エチルヘキシル、乳酸セチル、リンゴ酸ジイソステアリル、ジ−2−エチルヘキサン酸エチレングリコール、ジカプリン酸ネオペンチルグリコール、ジ−2−ヘプチルウンデカン酸グリセリン、トリ−2−エチルヘキサン酸グリセリン、トリ−2−エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ−2−エチルヘキサン酸ペンタンエリトリット等の合成エステル油類、ジメチルポリシロキサン、メチルフェニルポリシロキサン、ジフェニルポリシロキサン等の鎖状ポリシロキサン、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサンシロキサン等の環状ポリシロキサン、アミノ変性ポリシロキサン、ポリエーテル変性ポリシロキサン、アルキル変性ポリシロキサン、フッ素変性ポリシロキサン等の変性ポリシロキサン等のシリコーン油等の油剤類等が挙げられる。 The powdery cosmetic composition of the present invention can be blended with oily components that are usually used in cosmetics. Such oil components include, for example, macadamia nut oil, avocado oil, corn oil, olive oil, rapeseed oil, sesame oil, castor oil, safflower oil, cottonseed oil, jojoba oil, coconut oil, palm oil, liquid lanolin, hardened coconut oil, hardened Oil, molasses, hydrogenated castor oil, beeswax, candelilla wax, carnauba wax, botarou, lanolin, reduced lanolin, hard lanolin, jojoba oil, waxes, liquid paraffin, squalane, pristane, ozokerite, paraffin, ceresin, petrolatum, micro Hydrocarbons such as crystallin wax, oleic acid, isostearic acid, lauric acid, myristic acid, palmitic acid, higher fatty acids such as stearic acid, behenic acid, undecylenic acid, cetyl alcohol, stearyl alcohol, isostearyl High alcohols such as alcohol, behenyl alcohol, octyldodecanol, myristyl alcohol, cetostearyl alcohol, cetyl isooctanoate, isopropyl myristate, hexyldecyl isostearate, diisopropyl adipate, di-2-ethylhexyl sebacate, cetyl lactate, malic acid Diisostearyl, di-2-ethylhexanoic acid ethylene glycol, dicaprate neopentyl glycol, di-2-heptylundecanoic acid glycerin, tri-2-ethylhexanoic acid glycerin, tri-2-ethylhexanoic acid trimethylolpropane, tri Synthetic ester oils such as trimethylolpropane isostearate and pentane erythritol tetra-2-ethylhexanoate, dimethylpolysiloxane, methylphenylpolysiloxane Chain polysiloxanes such as xane and diphenylpolysiloxane, cyclic polysiloxanes such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexanesiloxane, amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, Examples thereof include oil agents such as silicone oil such as modified polysiloxane such as fluorine-modified polysiloxane.
油性成分に加え、界面活性剤類を配合することが、肌へのなじみ、パフへの取れ等の使用性の面から好ましい。かかる界面活性剤類としては、ラウリン酸ナトリウム、パルミチン酸ナトリウム等の脂肪酸セッケン類;ラウリル硫酸カリウム、アルキル硫酸トリエタノールアミンエーテル等のアニオン界面活性剤類;塩化ステアリルトリメチルアンモニウム、塩化ベンザルコニウム、ラウリルアミンオキサイド等のカチオン界面活性剤類;イミダゾリン系両性界面活性剤(2−ココイル−2−イミダゾリニウムヒドロキサイド−1−カルボキシエチロキシ2ナトリウム塩等)、ベタイン系界面活性剤(アルキルベタイン、アミドベタイン、スルホベタイン等)、アシルメチルタウリン等の両性界面活性剤類;ソルビタン脂肪酸エステル類(ソルビタンモノステアレート、セスキオレイン酸ソルビタン等)、グリセリン脂肪酸類(モノステアリン酸グリセリン等)、プロピレングリコール脂肪酸エステル類(モノステアリン酸プロピレングリコール等)、硬化ヒマシ油誘導体、グリセリンアルキルエーテル、POEソルビタン脂肪酸エステル類(POEソルビタンモノオレエート、モノステアリン酸ポリオキエチレンソルビタン等)、POEソルビット脂肪酸エステル類(POE−ソルビットモノラウレート等)、POEグリセリン脂肪酸エステル類(POE−グリセリンモノイソステアレート等)、POE脂肪酸エステル類(ポリエチレングリコールモノオレート、POEジステアレート等)、POEアルキルエーテル類(POE2−オクチルドデシルエーテル等)、POEアルキルフェニルエーテル類(POEノニルフェニルエーテル等)、プルロニック型類、POE・POPアルキルエーテル類(POE・POP2−デシルテトラデシルエーテル等)、テトロニック類、POEヒマシ油・硬化ヒマシ油誘導体(POEヒマシ油、POE硬化ヒマシ油等)、ショ糖脂肪酸エステル、アルキルグルコシド等の非イオン界面活性剤類等を挙げられる。中でも好ましい界面活性剤はHLB7以下の親油性非イオン界面活性剤であり、その配合量は、粉体化粧料重量に基づき0.1〜3重量%が好ましい。 In addition to the oil component, it is preferable to add a surfactant from the viewpoint of usability such as familiarity with the skin and removal to a puff. Examples of such surfactants include fatty acid soaps such as sodium laurate and sodium palmitate; anionic surfactants such as potassium lauryl sulfate and alkylethanol triethanolamine ether; stearyltrimethylammonium chloride, benzalkonium chloride and lauryl. Cationic surfactants such as amine oxides; imidazoline-based amphoteric surfactants (2-cocoyl-2-imidazolinium hydroxide-1-carboxyethyloxy disodium salt, etc.), betaine-based surfactants (alkylbetaines, amides) Amphoteric surfactants such as betaine, sulfobetaine, etc .; sorbitan fatty acid esters (such as sorbitan monostearate, sorbitan sesquioleate), glycerin fatty acids (glyceryl monostearate) Propylene glycol fatty acid esters (such as propylene glycol monostearate), hydrogenated castor oil derivatives, glycerin alkyl ether, POE sorbitan fatty acid esters (POE sorbitan monooleate, polyoxyethylene sorbitan monostearate, etc.), POE sorbit Fatty acid esters (POE-sorbitol monolaurate, etc.), POE glycerin fatty acid esters (POE-glycerin monoisostearate, etc.), POE fatty acid esters (polyethylene glycol monooleate, POE distearate, etc.), POE alkyl ethers (POE2) -Octyldodecyl ether, etc.), POE alkyl phenyl ethers (POE nonyl phenyl ether, etc.), Pluronic types, POE / POP alkyl ether Nonionic surface actives such as POE / POP2-decyltetradecyl ether, Tetronics, POE castor oil / hardened castor oil derivatives (POE castor oil, POE hardened castor oil, etc.), sucrose fatty acid esters, alkyl glucosides, etc. Examples include agents. Among them, a preferable surfactant is a lipophilic nonionic surfactant having an HLB of 7 or less, and the blending amount is preferably 0.1 to 3% by weight based on the weight of the powder cosmetic.
本発明の粉体化粧料には、本発明の効果を損なわない範囲で、通常化粧料で使用されるその他の任意成分を配合することができる。かかる任意成分としては、例えば、ポリエチレングリコール、グリセリン、1,3−ブチレングリコール、エリスリトール、ソルビトール、キシリトール、マルチトール、プロピレングリコール、ジプロピレングリコール、ジグリセリン、イソプレングリコール、1,2−ペンタンジオール、2,4−−ヘキシレングリコール、1,2−ヘキサンジオール、1,2−オクタンジオール等の多価アルコール類、ヒアルロン酸、ヒアルロン酸ナトリウム、ピロリドンカルボン酸ナトリウム、乳酸、乳酸ナトリウム等の保湿成分類、エタノール、イソプロパノール等の低級アルコール類、ビタミンA又はその誘導体、ビタミンB6塩酸塩,ビタミンB6トリパルミテート,ビタミンB6ジオクタノエート,ビタミンB2又はその誘導体,ビタミンB12,ビタミンB15又はその誘導体等のビタミンB類、α−トコフェロール,β−トコフェロール,γ−トコフェロール,ビタミンEアセテート等のビタミンE類、ビタミンD類、ビタミンH、パントテン酸、パンテチン、ピロロキノリンキノン等のビタミン類などが好ましく例示できる。 The powder cosmetic of the present invention can be blended with other optional components that are usually used in cosmetics within a range that does not impair the effects of the present invention. Examples of such optional components include polyethylene glycol, glycerin, 1,3-butylene glycol, erythritol, sorbitol, xylitol, maltitol, propylene glycol, dipropylene glycol, diglycerin, isoprene glycol, 1,2-pentanediol, 2 , 4-hexylene glycol, polyhydric alcohols such as 1,2-hexanediol, 1,2-octanediol, hyaluronic acid, sodium hyaluronate, sodium pyrrolidone carboxylate, lactic acid, sodium lactate and other moisturizing ingredients, Lower alcohols such as ethanol and isopropanol, vitamin A or derivatives thereof, vitamin B6 hydrochloride, vitamin B6 tripalmitate, vitamin B6 dioctanoate, vitamin B2 or derivatives thereof, vitamin B 2, Vitamin B such as vitamin B15 or its derivatives, α-tocopherol, β-tocopherol, γ-tocopherol, vitamin E such as vitamin E acetate, vitamin D, vitamin H, pantothenic acid, panthetin, pyrroloquinoline quinone, etc. Of these, vitamins can be preferably exemplified.
パラアミノ安息香酸系紫外線吸収剤、アントラニル酸系紫外線吸収剤、サリチル酸系紫外線吸収剤、桂皮酸系紫外線吸収剤、ベンゾフェノン系紫外線吸収剤、糖系紫外線吸収剤、2−(2’−ヒドロキシ−5’−t−オクチルフェニル)ベンゾトリアゾール、4−メトキシ−4’−t−ブチルジベンゾイルメタン等の有機紫外線吸収剤類を配合することによりより高いSPF値、PA値が得られるが、安全性を重視する場合にはこれら有機紫外線吸収剤を含まないことが好ましい。 Paraaminobenzoic acid UV absorbers, anthranilic acid UV absorbers, salicylic acid UV absorbers, cinnamic acid UV absorbers, benzophenone UV absorbers, sugar UV absorbers, 2- (2'-hydroxy-5 ' Higher SPF and PA values can be obtained by blending organic ultraviolet absorbers such as -t-octylphenyl) benzotriazole and 4-methoxy-4'-t-butyldibenzoylmethane, but safety is emphasized When it does, it is preferable not to contain these organic ultraviolet absorbers.
本発明の粉体化粧料は、上記の原料の組成を適宜変えて、種々の目的の粉体化粧料に適用することが出来る。本発明化粧料の種類としては、粉体化粧料の応用が、既に知られているものであれば特段の限定無く適用することができる。例えば、ファンデーション、下地パウダー、仕上げパウダー、チークカラー、アイカラー、紫外線防御化粧料、水使用ケーキ、両用ケーキ、ボディーパウダーなどが好適に例示できる。 The powder cosmetic of the present invention can be applied to powder cosmetics for various purposes by appropriately changing the composition of the above raw materials. As the types of the cosmetics of the present invention, any powder cosmetics can be applied without particular limitation as long as the application of the powder cosmetics is already known. For example, foundations, foundation powders, finishing powders, teak colors, eye colors, UV protection cosmetics, water-use cakes, amphibious cakes, body powders and the like can be preferably exemplified.
粉体化粧料の形態は、粉末状、固形状の何れでもよい。この中でも、本発明の効果が発揮されやすい形態としては、固形粉末状のメイクアップ化粧料が挙げられる。 The form of the powder cosmetic may be either powder or solid. Among these, as a form in which the effect of the present invention is easily exhibited, a solid powder makeup cosmetic is exemplified.
本発明の粉体化粧料は、常法に従い粉体成分と必要によりその他成分を均一に混合することによって調製することができる。この混合粉体をそのまま容器に充填し、ルースパウダーとして使用することも可能である。さらに、混合粉体を容器に充填した後プレスして、固形パウダーとすることも可能である。固形パウダーとする場合は、混合粉体に水、低級アルコール、揮発性シリコーン、軽質流動イソパラフィン等から選ばれる1種以上の揮発性溶剤を加えた後、プレスし、乾燥することが、使用性および保型性(割れにくさ)の点から好ましい。 The powder cosmetic of the present invention can be prepared by uniformly mixing the powder component and, if necessary, other components according to a conventional method. It is also possible to fill this mixed powder into a container as it is and use it as loose powder. Furthermore, the mixed powder can be filled into a container and then pressed to obtain a solid powder. In the case of a solid powder, after adding one or more volatile solvents selected from water, lower alcohol, volatile silicone, light liquid isoparaffin, etc. to the mixed powder, pressing and drying can be used. This is preferable from the viewpoint of shape retention (hardness to crack).
以下、実施例を挙げて本発明の粉体化粧料を具体的に説明する。 Hereinafter, the powder cosmetic of the present invention will be specifically described with reference to examples.
板状複合粉体(A)の調製
[調製例1]
板状粉体として平均粒子径8μmのセリサイト65重量部および平均粒子径30nmのステアリン酸アルミニウム処理微粒子酸化チタン35重量部を擂潰機を用いて擂潰混合処理を行い、微粒子酸化チタン被覆板状複合粉体(A1)を得た。
Preparation of plate-like composite powder (A) [Preparation Example 1]
As a plate-like powder, 65 parts by weight of sericite having an average particle diameter of 8 μm and 35 parts by weight of aluminum stearate-treated fine particle titanium oxide having an average particle diameter of 30 nm are subjected to a pulverizing and mixing process using a pulverizer, and a fine particle titanium oxide coated plate A composite powder (A1) was obtained.
[調製例2]
板状粉体として平均粒子径8μmのセリサイト47.5重量部および平均粒子径260nmの微粒子酸化亜鉛50重量部を擂潰機を用いて擂潰混合処理を行った後、これをイオン交換水500重量部に懸濁させ、そこに、ステアリン酸ナトリウム2.7重量部をイオン交換水100重量部に溶解した溶液を攪拌しながらゆっくりと加え、ろ過、洗浄、乾燥を行い、ステアリン酸により表面疎水化された微粒子酸化亜鉛被覆板状複合粉体(A2)を得た。
[Preparation Example 2]
A plate-like powder was subjected to a pulverization mixing treatment using 47.5 parts by weight of sericite having an average particle diameter of 8 μm and 50 parts by weight of fine zinc oxide having an average particle diameter of 260 nm using a pulverizer. Suspend in 500 parts by weight, and slowly add a solution of 2.7 parts by weight of sodium stearate dissolved in 100 parts by weight of ion-exchanged water while stirring, filter, wash and dry. Hydrophobized fine particle zinc oxide-coated plate composite powder (A2) was obtained.
球状複合粉体(B)の調製
[調製例3]
球状粉体として平均粒子径7μmの架橋ポリメチルメタクリレート粉末50重量部および平均粒子径35nmのジメチコン処理微粒子酸化チタン50重量部を擂潰機を用いて擂潰混合処理を行い、微粒子酸化チタン被覆球状複合粉体(B1)を得た。
Preparation of spherical composite powder (B) [Preparation Example 3]
As a spherical powder, 50 parts by weight of a crosslinked polymethylmethacrylate powder having an average particle diameter of 7 μm and 50 parts by weight of a dimethicone-treated fine particle titanium oxide having an average particle diameter of 35 nm are subjected to a pulverizing and mixing process using a pulverizer. A composite powder (B1) was obtained.
[調製例4]
球状粉体として平均粒子径7μmの架橋ポリメチルメタクリレート粉末50重量部および平均粒子径25nmのジメチコン処理微粒子酸化亜鉛50重量部を擂潰機を用いて擂潰混合処理を行い、微粒子酸化亜鉛被覆球状複合粉体(B2)を得た。
[Preparation Example 4]
As a spherical powder, 50 parts by weight of a crosslinked polymethylmethacrylate powder having an average particle diameter of 7 μm and 50 parts by weight of a dimethicone-treated fine particle zinc oxide having an average particle diameter of 25 nm are subjected to a pulverizing and mixing process using a pulverizer to form a spherical zinc oxide coated A composite powder (B2) was obtained.
in vitro SPFの測定
測定装置として、Labshere社製SPF Analyzer UV−1000Sを用い、サンプル塗布プレートとしては、資生堂医理化テクノロジー社製PA−1を使用した。上記調製例1〜4の複合粉体および市販の複合粉体を、それぞれ0.8mg/cm2の量で指で均一に塗布した。測定結果を表1に示す。
Measurement of in vitro SPF As a measuring device, SPF Analyzer UV-1000S manufactured by Labshere was used, and PA-1 manufactured by Shiseido Medical Rika Technology Co., Ltd. was used as a sample coating plate. The composite powders of Preparation Examples 1 to 4 and commercially available composite powders were each uniformly applied with a finger in an amount of 0.8 mg / cm 2 . The measurement results are shown in Table 1.
板状複合粉体(A)と球状複合粉体(B)の混合効果
酸化チタンまたは酸化亜鉛の面積当りの塗布量が一定になるように塗布量を調整し、複合粉体(A)または(B)単独の場合と、板状複合粉体(A)と球状複合粉体(B)を混合した場合のin vitro SPFを比較した。板状複合粉体(A)と球状複合粉体(B)は家庭用ミキサーを用いて混合した。結果を表2に示す。
Effect of mixing of plate-like composite powder (A) and spherical composite powder (B) The amount of application per area of titanium oxide or zinc oxide is adjusted, and composite powder (A) or ( B) The in vitro SPF was compared between the case where it was used alone and the case where the plate-like composite powder (A) and the spherical composite powder (B) were mixed. The plate-like composite powder (A) and the spherical composite powder (B) were mixed using a home mixer. The results are shown in Table 2.
表2から明らかなように、人の皮膚形状に類似した塗布プレートを使用し、in vitro SPFを測定した場合、板状複合粉体(A)と球状複合粉体(B)とを混合して使用することにより単独の場合に比べ顕著に高いSPF値が得られた。塗布プレートとして従来用いられた3M社製トランスポアサージカルテープを使用した場合は、板状と球状を混合してもSPF値の向上効果は見られなかった。 As is apparent from Table 2, when an in vitro SPF was measured using an application plate similar to human skin shape, the plate-like composite powder (A) and the spherical composite powder (B) were mixed. By using it, a significantly higher SPF value was obtained compared to the case of using it alone. When a 3M transpore surgical tape conventionally used as the coating plate was used, the effect of improving the SPF value was not seen even when the plate shape and the spherical shape were mixed.
複合粉体の塗布プレートへの付着状態
板状複合粉体(A)と球状複合粉体(B)の混合によるSPF値の向上効果の機構を考察するために、混合粉体を塗布した塗布プレートをキーエンス社製デジタルマイクロスコープを用いて300倍および1000倍の倍率で観察すると、球状複合粉体(B)が皮溝を模した溝に多く見られ、板状複合粉体(A)が皮丘を模した平面部に多く見られた。このことから板状複合粉体(A)と球状複合粉体(B)を混合することにより皮溝・皮丘のような凹凸構造を持つヒトの皮膚に隙間無く均一に付着させることができることが示唆された。
Adhesion state of composite powder on application plate In order to consider the mechanism of the effect of improving SPF value by mixing plate-like composite powder (A) and spherical composite powder (B), application plate coated with mixed powder Is observed at a magnification of 300 times and 1000 times using a digital microscope manufactured by Keyence Corporation, spherical composite powder (B) is often seen in grooves imitating skin grooves, and plate-like composite powder (A) is peeled off. Many were seen in the flat part imitating a hill. Therefore, by mixing the plate-like composite powder (A) and the spherical composite powder (B), it can be uniformly attached to the human skin having a concavo-convex structure such as a skin groove and a skin hill without a gap. It was suggested.
平均摩擦係数(MIU)の測定
平均摩擦係数(MIU)の測定は、カトーテック(株)製摩擦感テスタ−KES−SEを使用し、調製例1〜4の複合粉体を含む各種粉体を人工皮革上に0.5mg/cm2となるように均一に塗り広げ、荷重50gの条件下に求めた。結果を表3に示す。
Measurement of Average Friction Coefficient (MIU) Measurement of average friction coefficient (MIU) uses a friction tester-KES-SE manufactured by Kato Tech Co., Ltd. It was uniformly spread on the artificial leather so as to be 0.5 mg / cm 2 and obtained under the condition of a load of 50 g. The results are shown in Table 3.
(注4)日揮触媒化成社製カバーリーフPC−2035(酸化チタン30重量%)
(注5)日揮触媒化成社製ファンシーベール330TW(酸化亜鉛30重量%)
表3の結果から本発明で用いられる複合粉体は単純混合粉体に比べ、MIU値が低いことが示された。
(Note 5) Fancy Veil 330TW (30% by weight of zinc oxide) manufactured by JGC Catalysts & Chemicals
From the results in Table 3, it was shown that the composite powder used in the present invention had a lower MIU value than the simple mixed powder.
<実施例1〜5> <比較例1〜3>
表4に記載した処方のパウダーファンデーションを、以下に示す製法にて調製し、「伸びの良さ」、「肌へのなじみ」、「パフへの取れが良い」、「in vitro SPF」の各項目について評価した。結果を、併せて表1に示した。
<Examples 1-5><Comparative Examples 1-3>
The powder foundation of the formulation described in Table 4 was prepared by the following method, and each item of “Good elongation”, “Familiarity to skin”, “Good removal to puff”, “In vitro SPF” Was evaluated. The results are also shown in Table 1.
評価方法
「伸びの良さ」、「肌へのなじみ」、「パフへの取れが良い」に関する評価方法:女性専門パネル5名に各ファンデーション使用してもらい、評価した。
各項目別に、「良い(評点:2)」「どちらとも言えない(評点:1)」「悪い(評点:0)」の3段階で評価し、評点の平均点から下記基準で判定した。
[判定]:[評点の平均値]
5:1.8以上
4:1.5以上1.8未満
3:1.0以上1.5未満
2:0.3以上1.0未満
1:0.3未満
Evaluation method Evaluation method concerning “goodness of elongation”, “familiarity to skin”, and “good removal to puff”: Five female panels used each foundation and evaluated.
Each item was evaluated in three stages, “good (score: 2)”, “cannot say either (score: 1)”, and “bad (score: 0)”, and the average score was determined according to the following criteria.
[Judgment]: [Average score]
5: 1.8 or more 4: 1.5 or more and less than 1.8 3: 1.0 or more but less than 1.5 2: 0.3 or more but less than 1.0 1: less than 0.3
「in vitro SPF」
Labshere社製SPF Analyzer UV−1000Sを用い、サンプル塗布プレートとしては資生堂医理化テクノロジー社製PA−1を使用し、1.5mg/cm2の塗布量で測定した。
"In vitro SPF"
Using a SPF Analyzer UV-1000S manufactured by Labshere, PA-1 manufactured by Shiseido Medical Rika Technology Co., Ltd. was used as the sample coating plate, and the coating amount was 1.5 mg / cm 2 .
*7 日揮触媒化成社製ファンシーベル330TW(酸化亜鉛30重量%)
* 7 JGC Catalysts Chemical Fancy Bell 330TW (30% by weight of zinc oxide)
製造方法
A:成分1〜17を混合する。
B:成分1〜17の混合物に成分18〜19を添加し、混合する。
C:成分1〜19の混合物を金皿に充填し、プレス成形して、パウダーファンデーションを得た。
Production method A: Components 1 to 17 are mixed.
B: Add components 18-19 to the mixture of components 1-17 and mix.
C: A mixture of components 1 to 19 was filled in a metal pan and press-molded to obtain a powder foundation.
表4の結果から明らかなように、本発明に係わる実施例1〜4のパウダーファンデーションは、「伸びの良さ」、「肌へのなじみ」、「パフへの取れが良い」、「in vitro SPF」の全ての項目において優れたものであった。それに対し、比較例1〜3では、全ての項目を満足するものは得られなかった。また実施例1のパウダーファンデーションのin vivo SPFを日本化粧品工業会の標準試験法に従い測定した結果はSPF45、PA+++であった。本発明の粉体化粧料はヒトの皮膚において高いSPFが得られることが確認できた。 As is apparent from the results of Table 4, the powder foundations of Examples 1 to 4 according to the present invention have “good elongation”, “familiarity to skin”, “good removal to puff”, “in vitro SPF”. It was excellent in all items. On the other hand, in Comparative Examples 1-3, what satisfy | filled all the items was not obtained. Moreover, the results of measuring the in vivo SPF of the powder foundation of Example 1 according to the standard test method of the Japan Cosmetic Industry Association were SPF45 and PA ++. It was confirmed that the powder cosmetic of the present invention can obtain high SPF in human skin.
<実施例6>:粉白粉
(成分) (重量%)
1.調製例1の微粒子酸化チタン被覆板状複合粉体(A1) 20.0
2.調製例2の微粒子酸化亜鉛被覆板状複合粉体(A2) 10.0
3.調製例3の微粒子酸化チタン被覆球状複合粉体(B1) 8.0
4.調製例4の微粒子酸化亜鉛被覆球状複合粉体(B2) 5.0
5.ウレタンパウダー 5.0
6.セバシン酸イソステアリル処理セリサイト 10.0
7.酸化チタン 1.0
8.ベンガラ 0.1
9.黄酸化鉄 0.2
10.黒酸化鉄 0.05
11.雲母チタン 3.0
12.N−ラウロイルグルタミン酸処理タルク 残部
13.オクトキシグリセリン 0.5
<Example 6>: Powdered white powder (component) (% by weight)
1. Fine particle titanium oxide-coated plate-like composite powder (A1) 20.0 of Preparation Example 1
2. Fine zinc oxide-coated plate composite powder (A2) of Preparation Example 10.0
3. Fine particle titanium oxide-coated spherical composite powder (B1) of Preparation Example 8.0
4). Fine particle zinc oxide-coated spherical composite powder (B2) of Preparation Example 4 5.0
5. Urethane powder 5.0
6). Sericite treated with isostearyl sebacate 10.0
7). Titanium oxide 1.0
8). Bengala 0.1
9. Yellow iron oxide 0.2
10. Black iron oxide 0.05
11. Mica titanium 3.0
12 12. N-lauroylglutamic acid-treated talc balance 13 Octoxyglycerin 0.5
(製造方法)
A:成分1〜11を混合する。
B:成分1〜11の混合物に成分13を添加し、混合する。
本発明の粉白粉は肌なじみ等の使用性に優れ、塗布量1.5mg/cm2のin vitro SPFは28であった。
(Production method)
A: Components 1 to 11 are mixed.
B: Add component 13 to the mixture of components 1-11 and mix.
The powdered white powder of the present invention was excellent in usability such as familiarity with the skin, and the in vitro SPF with an application amount of 1.5 mg / cm 2 was 28.
本発明の粉体化粧料は、安全性、使用性及び紫外線防御効果に優れているため、パウダーファンデーションや白粉等として高い有用性が期待される。 Since the powder cosmetic of the present invention is excellent in safety, usability and UV protection effect, it is expected to be highly useful as a powder foundation or white powder.
Claims (2)
(A)粒子径5〜100nmの微粒子酸化チタンおよび/または粒子径5〜400nmの微粒子酸化亜鉛を粒子径1〜50μmの板状粉体に対し、該微粒子酸化チタンおよび/または該微粒子酸化亜鉛:該板状粉体の比率が2:8〜7:3の重量比率で被覆した光輝性を有さない1種または2種以上の板状複合粉体:10〜60重量%、および
(B)粒子径5〜100nmの微粒子酸化チタンおよび/または粒子径5〜400nmの微粒子酸化亜鉛を粒子径1〜50μmの球状粉体に対し、該微粒子酸化チタンおよび/または該微粒子酸化亜鉛:該球状粉体の比率が2:8〜7:3の重量比率で被覆した1種または2種以上の球状複合粉体:4〜50重量%
を含有することを特徴とする粉体化粧料。 The following components (A) and (B) (weight% representing the amount of each component is based on the total weight of the powder cosmetic):
(A) Fine particle titanium oxide having a particle diameter of 5 to 100 nm and / or fine particle zinc oxide having a particle diameter of 5 to 400 nm to a plate-like powder having a particle diameter of 1 to 50 μm , the fine particle titanium oxide and / or the fine particle zinc oxide: One or two or more kinds of plate-like composite powders coated with a weight ratio of the plate- like powders of 2: 8 to 7: 3 and having no glitter: 10 to 60% by weight, and (B) Fine particle titanium oxide and / or fine particle zinc oxide having a particle diameter of 5 to 100 nm and / or fine particle zinc oxide having a particle diameter of 5 to 400 nm and spherical powder having a particle diameter of 1 to 50 μm are used. ratio of 2: 8-7: 1 or more kinds of the spherical composite powder coated with 3 weight ratio: 4-50 wt%
A powder cosmetic comprising:
(A1)粒子径5〜100nmの微粒子酸化チタンを粒子径1〜50μmの板状粉体に対し、該微粒子酸化チタン:該板状粉体の比率が2:8〜7:3の重量比率で被覆した光輝性を有さない板状複合粉体:3〜40重量%、
(A2)粒子径5〜400nmの微粒子酸化亜鉛を粒子径1〜50μmの板状粉体に対し、該微粒子酸化亜鉛:該板状粉体の比率が2:8〜7:3の重量比率で被覆した光輝性を有さない板状複合粉体:3〜40重量%、
(B1)粒子径5〜100nmの微粒子酸化チタンを粒子径1〜50μmの球状粉体に対し、該微粒子酸化チタン:該球状粉体の比率が2:8〜7:3の重量比率で被覆した球状複合粉体:2〜30重量%、および
(B2)粒子径5〜400nmの微粒子酸化亜鉛を粒子径1〜50μmの球状粉体に対し、該微粒子酸化亜鉛:該球状粉体の比率が2:8〜7:3の重量比率で被覆した球状複合粉体:2〜30重量%
を含有することを特徴とする請求項1に記載の粉体化粧料。 The following components (A1), (A2), (B1) and (B2) (weight% representing the amount of each component is based on the total weight of the powder cosmetic):
(A1) relative to the plate-like powder having a particle diameter particle size of fine particles of titanium oxide of 5 to 100 nm 1 to 50 [mu] m, fine particles of titanium oxide: said plate ratio of the powder 2: 8-7: 3 weight ratio Covered plate-like composite powder having no glitter: 3 to 40% by weight,
(A2) The fine zinc oxide particles having a particle diameter of 5 to 400 nm and the plate powder having a particle diameter of 1 to 50 μm are in a weight ratio of 2: 8 to 7: 3. Covered plate-like composite powder having no glitter: 3 to 40% by weight,
(B1) Fine particle titanium oxide having a particle size of 5 to 100 nm was coated on a spherical powder having a particle size of 1 to 50 μm at a weight ratio of the fine particle titanium oxide: the spherical powder of 2: 8 to 7: 3. Spherical composite powder: 2 to 30% by weight, and (B2) fine zinc oxide having a particle size of 5 to 400 nm and spherical powder having a particle size of 1 to 50 μm, the ratio of the fine particle zinc oxide to the spherical powder is 2. : Spherical composite powder coated at a weight ratio of 8 to 7: 3: 2 to 30% by weight
The powder cosmetic according to claim 1, comprising:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011115672A JP4880078B1 (en) | 2011-05-24 | 2011-05-24 | Powder cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011115672A JP4880078B1 (en) | 2011-05-24 | 2011-05-24 | Powder cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JP4880078B1 true JP4880078B1 (en) | 2012-02-22 |
JP2012240999A JP2012240999A (en) | 2012-12-10 |
Family
ID=45851215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011115672A Active JP4880078B1 (en) | 2011-05-24 | 2011-05-24 | Powder cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4880078B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013221148A (en) * | 2012-04-19 | 2013-10-28 | Croda Japan Kk | Particulate ultraviolet ray absorbing material, and cosmetic product and resin composition compounded therewith |
EP3981888A1 (en) * | 2020-08-19 | 2022-04-13 | Schill + Seilacher GmbH | Finishing agent for leather |
CN114401706A (en) * | 2020-03-30 | 2022-04-26 | 株式会社高丝 | Cosmetic material containing powder |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106924054A (en) * | 2015-12-31 | 2017-07-07 | 默克专利股份有限公司 | The inorganic pigment being made up of special spherical composite pellets is used as sun-proof reinforcing agent |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002047126A (en) * | 2000-07-28 | 2002-02-12 | Kao Corp | Composite powder |
JP2003277217A (en) * | 2002-03-25 | 2003-10-02 | Kose Corp | Cosmetic |
JP2005179249A (en) * | 2003-12-18 | 2005-07-07 | Kao Corp | Powder cosmetic |
JP2010037211A (en) * | 2008-07-31 | 2010-02-18 | Pola Chem Ind Inc | Solid powder cosmetic |
-
2011
- 2011-05-24 JP JP2011115672A patent/JP4880078B1/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002047126A (en) * | 2000-07-28 | 2002-02-12 | Kao Corp | Composite powder |
JP2003277217A (en) * | 2002-03-25 | 2003-10-02 | Kose Corp | Cosmetic |
JP2005179249A (en) * | 2003-12-18 | 2005-07-07 | Kao Corp | Powder cosmetic |
JP2010037211A (en) * | 2008-07-31 | 2010-02-18 | Pola Chem Ind Inc | Solid powder cosmetic |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013221148A (en) * | 2012-04-19 | 2013-10-28 | Croda Japan Kk | Particulate ultraviolet ray absorbing material, and cosmetic product and resin composition compounded therewith |
CN114401706A (en) * | 2020-03-30 | 2022-04-26 | 株式会社高丝 | Cosmetic material containing powder |
EP3981888A1 (en) * | 2020-08-19 | 2022-04-13 | Schill + Seilacher GmbH | Finishing agent for leather |
Also Published As
Publication number | Publication date |
---|---|
JP2012240999A (en) | 2012-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20200139162A (en) | Cosmetic | |
JP6514859B2 (en) | Makeup cosmetics | |
JP5808083B2 (en) | Sunscreen cosmetics | |
JP2018530580A (en) | Composition comprising soft focus filler and composite pigment based on non-spherical alumina and metal oxide | |
JP4943128B2 (en) | Powder-containing cosmetic | |
JP2016124846A (en) | Powder cosmetics | |
JP2008143837A5 (en) | ||
JP2018008910A (en) | Sunscreen cosmetics | |
WO2020090874A1 (en) | Emulsified cosmetic and method for producing same | |
JP6359295B2 (en) | Water-in-oil emulsified cosmetic and method for producing the same | |
JP4880078B1 (en) | Powder cosmetics | |
EP3972552A1 (en) | Cosmetic compositions for soft-focus | |
JP2007320906A (en) | Fine wrinkle improver | |
JP6462583B2 (en) | Surface-treated powder using theanine and cosmetic containing the same | |
JP2017048158A (en) | Makeup cosmetic | |
JP2008137944A (en) | Powdery material for cosmetic and cosmetic containing the same | |
EP3716935B1 (en) | Cosmetic composition for blurring surface imperfections of skin | |
JP5016891B2 (en) | Powder cosmetics | |
JP4734034B2 (en) | Cosmetics containing powder | |
JP6064192B2 (en) | Powder cosmetics | |
JP2017122060A (en) | Body odor suppressing composition | |
JP5133119B2 (en) | Cosmetic powder | |
JP2020164462A (en) | Cosmetic | |
WO2010140470A1 (en) | Composite powder and makeup cosmetic preparation containing same | |
US12059487B2 (en) | Structurally diverse, stable, and radiation-protective particle matrix sunscreen and cosmetic compositions and related methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20111129 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20111130 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4880078 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20141209 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |